Who is sponsoring NCT04392817?

NCT04392817 is sponsored by Alaa Mamdouh.

What drugs are being tested in NCT04392817?

Interventions in NCT04392817: Arabic Articulatory Error Remediation software program.

What condition does NCT04392817 study?

NCT04392817 studies Velopharyngeal Insufficiency, Articulation Disorders, Hypernasality Syndrome Due to Velopharyngeal Weakness.

Is NCT04392817 still recruiting?

NCT04392817 is currently completed. Last updated 20 May 2020.

Last reviewed 2020-05-20 · How we verify

NCT04392817

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy of an Arabic Articulatory Error Remediation Software Program in Patients With Velopharyngeal Valve Dysfunction:

Completed NA Last updated 20 May 2020

What this trial tests

NA trial testing Arabic Articulatory Error Remediation software program in Velopharyngeal Insufficiency in 40 participants. Completed in 9 February 2019.

Timeline

2 January 2018

Primary endpoint
23 January 2019

9 February 2019

Quick facts

Lead sponsor	Alaa Mamdouh
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	40
Start date	2 January 2018
Primary completion	23 January 2019
Estimated completion	9 February 2019
Sites	1 location across Egypt

Drugs / interventions tested

Arabic Articulatory Error Remediation software program

Conditions studied

Velopharyngeal Insufficiency — all drugs for Velopharyngeal Insufficiency →
Articulation Disorders — all drugs for Articulation Disorders →
Hypernasality Syndrome Due to Velopharyngeal Weakness — all drugs for Hypernasality Syndrome Due to Velopharyngeal Weakness →

Sponsor

Alaa Mamdouh

Who can join

5 and older, any sex, with Velopharyngeal Insufficiency or Articulation Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To develop a remediation software program that is specific for correcting speech errors in patients with velopharyngeal dysfunction in the Arabic language and test its efficacy, on one group comparing pre and post results

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Velopharyngeal Insufficiency

Currently open trials in the same condition.

NCT07264036 — Velopharyngeal Dysfunction in Head & Neck Cancer Patients, Pilot Study · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04392817 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Alaa Mamdouh
Last refreshed: 20 May 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04392817.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing